CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the recipient of a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 1,444,389 shares, an increase of 144,438,800.0% from the July 15th total of 1 shares. Based on an average daily volume of 10,945,936 shares, the days-to-cover ratio is currently 0.1 days.

CNBX Pharmaceuticals Trading Up 100.0%

Shares of CNBX Pharmaceuticals stock opened at $0.00 on Wednesday. CNBX Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.00.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.